A retrospective study of the MDS criteria for prodromal Parkinson’s disease in the general population
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A retrospective study of the MDS criteria for prodromal Parkinson’s disease in the general population ; volume:10 ; number:1 ; day:26 ; month:6 ; year:2024 ; pages:1-7 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (26.6.2024), 1-7, 12.2024
- Urheber
-
Klerk, Gijs W. de
Laar, Teus van
Meles, Sanne K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00739-6
- URN
-
urn:nbn:de:101:1-2409162109300.865281044091
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klerk, Gijs W. de
- Laar, Teus van
- Meles, Sanne K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A look back at the prodromal findings in Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
A cellular model for the prodromal phase of sporadic Parkinson's disease
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned
Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
Prodromal sensory neuropathy in Pink1-/-SNCAA53T double mutant Parkinson mice
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
A look back at the prodromal findings in Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
A cellular model for the prodromal phase of sporadic Parkinson's disease
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned
Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
Prodromal sensory neuropathy in Pink1-/-SNCAA53T double mutant Parkinson mice
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
A look back at the prodromal findings in Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Clinical Criteria for the Diagnosis of Parkinson’s Disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
A cellular model for the prodromal phase of sporadic Parkinson's disease
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned
Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
Prodromal sensory neuropathy in Pink1-/-SNCAA53T double mutant Parkinson mice